珍寶島(603567.SH):複方芩蘭口服液和雙黃連口服液佔當期主營業務收入比例較小
格隆匯2月3日丨珍寶島(603567.SH)公佈,公司股票交易於2020年1月22日、2020年1月23日、2020年2月3日連續三個交易日內日收盤價格漲幅偏離值累計超過20%,根據《上海證券交易所交易規則》有關規定,屬於股票交易異常波動。
公司兩種廣譜抗病毒藥物複方芩蘭口服液和雙黃連口服液:2018年度營業收入分別約為780萬元和300萬元;2019年截至三季度末營業收入分別約為2,500萬元和550萬元,佔當期主營業務收入的比例較小,分別為1.25%和0.27%。
複方芩蘭口服液和雙黃連口服液兩種藥品,截止到2019年三季度營業收入佔公司當期主營業務收入比例較小,敬請廣大投資者理性投資,注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.